Provided by Tiger Trade Technology Pte. Ltd.

Gain Therapeutics, Inc.

1.73
+0.05002.98%
Volume:787.47K
Turnover:1.39M
Market Cap:75.50M
PE:-3.40
High:1.84
Open:1.70
Low:1.69
Close:1.68
52wk High:4.34
52wk Low:1.53
Shares:43.64M
Float Shares:42.34M
Volume Ratio:1.35
T/O Rate:1.86%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.5092
EPS(LYR):-0.6115
ROE:-268.30%
ROA:-95.51%
PB:6.69
PE(LYR):-2.83

Loading ...

Gain Therapeutics CEO to speak at H.C. Wainwright Neuro Perspectives Summit

Reuters
·
Jun 10

Gain Therapeutics (GANX) Receives a Buy from H.C. Wainwright

TIPRANKS
·
Jun 09

Analysts Offer Insights on Healthcare Companies: Gain Therapeutics (GANX) and Travere Therapeutics (TVTX)

TIPRANKS
·
May 28

Shrader Reiterates Buy on GANX as Parkinson’s Data Strengthens GT-02287 Profile; $5 Price Target Maintained

TIPRANKS
·
May 27

Gain Therapeutics presents data from Phase 1b study of GT-02287

TIPRANKS
·
May 26

BRIEF-Gain Therapeutics Says MDS-UPDRS Scores Remain Stable After 150 Days Of GT-2287 Treatment

Reuters
·
May 26

Gain Therapeutics Inc - Mds-Updrs Scores Remain Stable After 150 Days of GT-2,287 Treatment

THOMSON REUTERS
·
May 26

Gain Therapeutics Inc - 4.8 Point Difference in Mds-Updrs Scores at Day 150 Between Glusph Groups

THOMSON REUTERS
·
May 26

Gain Therapeutics reports stable MDS-UPDRS scores at Day 150 in Phase 1b trial of Parkinson’s drug GT-02287

Reuters
·
May 26

Gain Therapeutics Presents Positive Interim Data from Phase 1b Clinical Study of GT-02287 at 3rd International GBA1 Meeting 2026

GlobeNewswire
·
May 26

Gain Therapeutics price target lowered to $8 from $10 at Roth Capital

TIPRANKS
·
May 13

Gain Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 12

Gain Therapeutics Q1 loss per share narrows

Reuters
·
May 11

Gain Therapeutics Q1 EPS $(0.13) Beats $(0.14) Estimate

Benzinga Earnings
·
May 11

Press Release: Gain Therapeutics Reports Financial Results for First Quarter 2026 and Provides Corporate Update

Dow Jones
·
May 11

Gain Therapeutics Inc expected to post a loss of 14 cents a share - Earnings Preview

Reuters
·
May 08

Gain Therapeutics announces annual shareholder meeting

Reuters
·
Apr 29

Gain Therapeutics to give oral presentation at International GBA1 Meeting 2026

Reuters
·
Apr 24

Gain Therapeutics Announces Oral Presentation at 3Rd International Gba1 Meeting 2026

THOMSON REUTERS
·
Apr 24

Gain Therapeutics Announces Oral Presentation at 3rd International GBA1 Meeting 2026

GlobeNewswire
·
Apr 24